Article
Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systemic Review and Meta-Analysis
2026-03-23
Abstract excerpt
<h4>Background: </h4> Outcomes in chronic myeloid leukemia (CML) remain heterogeneous despite effective BCR::ABL1 tyrosine kinase inhibitors (TKIs). Somatic mutations in epigenetic regulators, particularly additional sex combs like 1 (ASXL1), have been implicated in adverse prognosis, but their clinical impact in CML has not been systematically defined. <h4>Methods:</h4> A systematic review was conducted using CIN...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d4dc4c8e-a645-5916-b142-0a988d4a61a4
- DOI
- 10.20944/preprints202603.1788.v1
